Efficient adenoviral transfer of NF-κB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis

International Journal of Cancer

Volumn 80, Issue 2, 1999, Pages 320-323

  Bakker, Talitha R ^a,b   Reed, Darryl ^a   Renno, Toufic ^a   Jongeneel, C Victor ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL;

ADENOVIRIDAE; APOPTOSIS; DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; MELANOMA; NF-KAPPA B; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033579807     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990118)80:2<320::AID-IJC24>3.0.CO;2-K     Document Type: Article

References (22)

1. ALEXANDER, H.R., JR., BARTLETT, D.L. and LIBUTTI, S.K., Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver. Cancer J. Sci. Amer., 4, 2-11 (1998).
2. BECKER, T.C., NOEL, R.J., COATS, W.S., GOMEZ-FOIX, A.M., ALAM, T., GERARD, R.D. and NEWGARD, C.B., Use of recombinant adenovirus for metabolic engineering of mammalian cells. Meth. Cell Biol., 43, 161-189 (1994).
3. BEG, A.A. and BALTIMORE, D., An essential role for NF-κB in preventing TNFα-induced cell death. Science, 274, 782-784 (1996).
4. BROWN, K., GERSTBERGER, S., CARLSON, L., FRANZOSO, G. and SIEBENLIST, U., Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation. Science, 267, 1485-1488 (1995).
5. CARSWELL, E.A., OLD, L.J., KASSEL, R.L., GREEN, S., FIORE, N. and WILLIAMSON, B., An endotoxin-induced serum factor that causes necrosis of tumors. Proc. nat. Acad. Sci. (Wash.), 72, 3666-3670 (1975).
6. EVAN, G.I., LEWIS, G.K., RAMSAY, G. and BISHOP, J.M., Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. cell. Biol., 5, 3610-3616 (1985).
7. HSU, H., HUANG, J., SHU, H.B., BAICHWAL, V. and GOEDDEL, D.V., TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4, 387-396 (1996a).
8. HSU, H., SHU, H.B., PAN, M.G. and GOEDDEL, D.V., TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84, 299-308 (1996b).
9. JÄÄTTELÄ, M., Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab. Invest., 64, 724-742 (1991).
10. KRIEGLER, M., PEREZ, C., DEFAY, K., ALBERT, I. and LU, S.D., A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell, 53, 45-53 (1988).
11. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
12. LEJEUNE, F., LIÉNARD, D., EGGERMONT, A., SCHRAFFORDT KOOPS, H., ROSENKAIMER, F., GERAIN, J., KLAASE, J., KROON, B., VANDERVEKEN, J. and SCHMITZ, P., Rationale for using TNFα and chemotherapy in regional therapy of melanoma. J. cell. Biochem., 56, 52-61 (1994).
13. MALININ, N.L., BOLDIN, M.P., KOVALENKO, A.V. and WALLACH, D., MAP3K-related kinase involved in NFκB induction by TNF, Cd95 and II-1. Nature (Lond.), 385, 540-544 (1997).
14. MILLER, D.K., The role of the caspase family of cysteine proteases in apoptosis. Semin. Immunol., 9, 35-49 (1997).
15. REED, D.S., ROMERO, P., RIMOLDI, D., CEROTTINI, J.C., SCHAACK, J. and JONGENEEL, C.V., Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen. Int. J. Cancer, 72, 1045-1055 (1997).
16. SCHIEVELLA, A.R., CHEN, J.H., GRAHAM, J.R. and LIN, L.L., MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. biol. Chem., 272, 12069-12075 (1997).
17. STANGER, B.Z., LEDER, P., LEE, T.H., KIM, E. and SEED, B., RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523 (1995).
18. TARTAGLIA, L.A., AVRES, T.M., WONG, G.H. and GOEDDEL, D.V., A novel domain within the 55 kd TNF receptor signals cell death. Cell, 74, 845-853 (1993).
19. TARTAGLIA, L.A. and GOEDDEL, D.V., Two TNF receptors. Immunol. Today, 13, 151-153 (1992).
20. VAN ANTWERP, D.J., MARTIN, S.J., KAFRI, T., GREEN, D.R. and VERMA, I.M., Suppression of TNFα-induced apoptosis by NF-κB. Science, 274, 787-789 (1996).
21. VASSALLI, P., The pathophysiology of tumor necrosis factors. Ann. Rev. Immunol., 10, 411-452 (1992).
22. WANG, C.Y., MAYO, M.W. and BALDWIN, A.S., JR., TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science, 274, 784-787 (1996).